Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
186 studies found for:    "Eye Diseases, Hereditary" OR "Peters plus syndrome"
Show Display Options
Rank Status Study
21 Completed
Has Results
Trial of Rituximab for Graves' Ophthalmopathy
Condition: Thyroid-associated Ophthalmopathy
Interventions: Drug: Rituximab;   Drug: Saline;   Drug: Methylprednisolone
22 Recruiting Vision Response to Dopamine Replacement
Conditions: Albinism;   Oculocutaneous Albinism
Intervention: Drug: Levodopa/carbidopa
23 Completed Gene Therapy for Gyrate Atrophy
Condition: Gyrate Atrophy
Intervention: Procedure: Gene therapy
24 Completed Slowing the Degenerative Process, Long Lasting Effect of Hyperbaric Oxygen Therapy in Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Procedure: hyperbaric oxygen therapy
25 Recruiting Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Conditions: Corneal Dystrophies, Hereditary;   Corneal Disease
Intervention:
26 Completed Autosomal Dominant Retinitis Pigmentosa: Prevalence of Known Genes Identification of New Loci / Genes
Condition: Autosomal Dominant Retinitis Pigmentosa
Intervention: Genetic: genetic analysis
27 Recruiting Repository for Inherited Eye Diseases
Conditions: Retinitis Pigmentosa;   Inherited Ophthalmic Diseases
Intervention:
28 Not yet recruiting Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease
Condition: Graves Ophthalmopathy
Interventions: Radiation: External beam radiotherapy;   Drug: intravenous corticosteroids (methylprednisolone)
29 Active, not recruiting Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: UF-021;   Drug: Placebo
30 Completed Morphometric Analysis of Orbital Structures in Graves´ Orbitopathy
Condition: Dysthyroid Orbitopathy
Intervention:
31 Completed Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the Eye
Condition: Retinitis Pigmentosa
Intervention: Drug: Ciliary Neurotrophic Factor Implant NT-501
32 Active, not recruiting TES for the Treatment of RP
Condition: Retinitis Pigmentosa
Intervention: Device: Transcorneal electrical stimulation
33 Terminated Study of Dietary N-3 Fatty Acids in Patients With Retinitis Pigmentosa and Usher Syndrome
Conditions: Usher Syndrome;   Retinitis Pigmentosa
Intervention:
34 Recruiting Study of Endothelial Keratoplasty Outcomes
Conditions: Fuchs' Endothelial Corneal Dystrophy;   Bullous Keratopathy;   Iridocorneal Endothelial Syndrome;   Posterior Polymorphous Dystrophy
Intervention: Procedure: endothelial keratoplasty
35 Enrolling by invitation A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of UshStat® in Patients With Usher Syndrome Type 1B
Condition: Usher Syndrome Type 1b
Intervention: Drug: UshStat
36 Completed Rituximab in the Treatment of Graves' Disease
Conditions: Graves´ Disease;   Thyroid Associated Ophthalmopathy
Interventions: Drug: Methimazole;   Drug: Rituximab;   Biological: Immunization with various vaccines
37 Recruiting Study of Selected X-Linked Disorders: Aicardi Syndrome
Conditions: Aicardi Syndrome;   Brain Disorders
Intervention:
38 Completed Randomized Trial for Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: Vitamin A;   Drug: Nutritional Supplement
39 Active, not recruiting Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations
Conditions: Amaurosis of Leber;   Retinal Diseases
Intervention: Genetic: rAAV2-CBSB-hRPE65
40 Active, not recruiting DHA and X-Linked Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa;   X-linked Genetic Diseases
Intervention: Drug: docosahexaenoic acid OR corn/soy oil placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years